Physician profile
Michael G Hughes
NPI 1831133644
$4,721.78
in general payments reported to CMS, 2019-2025
13 companies · $1,314 in 2025
The $1,314 reported for 2025 was more than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2021: $1,955 · 2022: $177 · 2023: $422 · 2024: $20.83 · 2025: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128 · Consulting Fee: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.58 |
| Consulting Fee | $630.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,879.77 | 2021-2023 | Signia |
| Enterra Medical, INC. | $1,148.43 | 2022-2025 | |
| Horizon Therapeutics Plc | $404.36 | 2019 | |
| Medtronic USA, INC. | $401.80 | 2019 | |
| Evoke Pharma, INC. | $308.04 | 2025 | |
| Merz North America, INC. | $250.00 | 2021 | |
| Merit Medical Systems INC | $123.84 | 2025 | Esophyx |
| Alcresta Therapeutics, INC. | $57.32 | 2023 | Relizorb |
| Vertex Pharmaceuticals Incorporated | $47.11 | 2025 | |
| Phathom Pharmaceuticals, INC. | $34.99 | 2025 | Voquezna |
| Wright Medical Technology, INC. | $25.76 | 2019 | |
| Lexington Medical, INC. | $20.83 | 2024 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Abbvie INC. | $19.53 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.